These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3082602)

  • 1. Transdifferentiated hepatocytes in rat pancreas.
    Rao MS; Scarpelli DG; Reddy JK
    Curr Top Dev Biol; 1986; 20():63-78. PubMed ID: 3082602
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of hepatocytes in the pancreas of copper-depleted rats following copper repletion.
    Rao MS; Subbarao V; Reddy JK
    Cell Differ; 1986 Mar; 18(2):109-17. PubMed ID: 3513967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rodent hepatocarcinogenic peroxisome proliferators induce proliferation of rat hepatocytes in primary mixed cultures with rat liver epithelial cells.
    Perrone CE; Williams GM
    Cancer Lett; 1998 Jan; 123(1):27-33. PubMed ID: 9461014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and origin of hepatocytes in rat pancreas.
    Reddy JK; Rao MS; Qureshi SA; Reddy MK; Scarpelli DG; Lalwani ND
    J Cell Biol; 1984 Jun; 98(6):2082-90. PubMed ID: 6202703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone inhibits DNA synthesis of rat hepatocytes induced by partial hepatectomy or mitogen (ciprofibrate).
    Rao MS; Subbarao V
    Cell Prolif; 1997 Jan; 30(1):1-5. PubMed ID: 9332491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
    Graham MJ; Winham MA; Old SL; Gray TJ
    Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicological evaluation of peroxisome proliferators. Further cellular and molecular aspects.
    Passilly P; Pacot C; Jannin B; Cherkaoui Malki M; Bardot O; Caira F; Clemencet MC; Latruffe N
    Ann N Y Acad Sci; 1996 Dec; 804():716-8. PubMed ID: 8993603
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes.
    Feller DR; Singh Y; Shirhatti VR; Kocarek TA; Liu CT; Krishna G
    Hepatology; 1987; 7(3):508-16. PubMed ID: 3570161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of eicosanoid metabolism in carcinogenesis by peroxisome proliferators.
    Glauert HP; Hong JT; Leung LK; Wilson MW
    Ann N Y Acad Sci; 1996 Dec; 804():719-21. PubMed ID: 8993604
    [No Abstract]   [Full Text] [Related]  

  • 10. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
    Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
    Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver.
    Wilson MW; Leung LK; Hong JT; Glauert HP
    Adv Exp Med Biol; 1997; 400A():439-45. PubMed ID: 9547588
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of peroxisome proliferation in hepatocytes transplanted into the anterior chamber of the eye. A model system for the evaluation of xenobiotic-induced effects.
    Rao MS; Thorgeirsson S; Reddy MK; Lalwani ND; Evarts RE; Usman MI; Singh B; Reddy JK
    Am J Pathol; 1986 Sep; 124(3):519-27. PubMed ID: 3532814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation.
    Rao MS; Subbarao V
    Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity.
    Li Y; Leung LK; Glauert HP; Spear BT
    Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences in the hepatic response to a potent peroxisome proliferator.
    Makowska JM; Bonner FW; Goldfarb PS; Gibson GG
    Biochem Soc Trans; 1989 Dec; 17(6):1072-3. PubMed ID: 2628085
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium as a permissive factor but not an initiation factor in DNA synthesis induction in cultured rat hepatocytes by the peroxisome proliferator ciprofibrate.
    Bennett AM; Williams GM
    Biochem Pharmacol; 1993 Dec; 46(12):2219-27. PubMed ID: 8274155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes.
    Foxworthy PS; White SL; Hoover DM; Eacho PI
    Toxicol Appl Pharmacol; 1990 Jul; 104(3):386-94. PubMed ID: 1974728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
    Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP
    Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator.
    Awasthi YC; Singh SV; Goel SK; Reddy JK
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
    Perrone CE; Shao L; Williams GM
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.